US · CYH · MEDICAL - CARE FACILITIES
Community Health Systems, Inc. (CYH) intrinsic value and stock valuation
$1.62as of 2026-11-21 · Mkt cap 415.98M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Community Health Systems, Inc. DCF and intrinsic value
InvestorsCraft values CYH with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from CYH’s statements →
Community Health Systems, Inc. Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $12.5B | $12.6B | $12.5B | $12.2B | $12.4B |
| Operating income | -$-9.92B | $542M | $957M | $821M | $1.4B |
| Net income | $509M | -$-516M | -$-133M | $46M | $230M |
| EPSd | $3.77M | -$-3.91M | -$-1.02M | $353.7K | $1.76M |
| Operating cash flow | $543M | $480M | $210M | $300M | -$-131M |
| Capital expenditure | -$-335M | -$-360M | -$-467M | -$-415M | -$-469M |
| Free cash flow | $208M | $120M | -$-257M | -$-115M | -$-600M |
| Total assets | $13.2B | $14.1B | $14.5B | $14.7B | $15.2B |
| Total debt | $11.6B | $12.1B | $12.2B | $12.4B | $12.8B |
| Net debt | $11.3B | $12.1B | $12.1B | $12.3B | $12.3B |
| Total equity | -$-837M | -$-1.32B | -$-824M | -$-734M | -$-810M |
| Cash and short-term investments | $260M | $37M | $38M | $118M | $507M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $12.5B | $12.6B | $12.5B | $12.2B | $12.4B |
| Cost of revenue | $11.4B | $7.36B | $7.41B | $7.31B | $7.28B |
| Gross profit | $1.08B | $5.27B | $5.08B | $4.91B | $5.08B |
| Research and development expenses | $0.00 | $0.00 | $80M | $85M | $108M |
| Selling, general and administrative expenses | $0.00 | $299M | $319M | $317M | $308M |
| Other expenses | $11B | $4.43B | $3.73B | $3.68B | $3.27B |
| Operating expenses | $11B | $4.73B | $4.13B | $4.09B | $3.68B |
| Cost and expenses | $22.4B | $12.1B | $11.5B | $11.4B | $11B |
| Interest income | $0.00 | $3M | $2M | $0.00 | $0.00 |
| Interest expense | $870M | $863M | $832M | $858M | $885M |
| Depreciation and amortization | $426M | $406M | $425M | $449M | $432M |
| Ebitda | $2.02B | $1.25B | $1.3B | $1.17B | $1.71B |
| Operating income | -$-9.92B | $542M | $957M | $821M | $1.4B |
| Total other income/expenses, net | $10.6B | -$-825M | -$-750M | -$-472M | -$-903M |
| Income before tax | $724M | -$-283M | $207M | $349M | $499M |
| Income tax expense | $48M | $79M | $191M | $170M | $131M |
| Net income | $509M | -$-516M | -$-133M | $46M | $230M |
| Weighted average shares outstanding | $134M | $132.1M | $130.4M | $128.8M | $126.8M |
| Weighted average diluted shares outstanding | $135M | $132.1M | $130.5M | $130.1M | $130.6M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $260M | $37M | $38M | $118M | $507M |
| Net receivables | $2.26B | $2.45B | $2.36B | $2.14B | $2.18B |
| Inventory | $322M | $331M | $328M | $353M | $355M |
| Total current assets | $3.23B | $3.3B | $3.21B | $3.08B | $3.48B |
| Property, plant and equipment, net | $5.12B | $5.4B | $5.87B | $6.1B | $6.22B |
| Goodwill and intangible assets | $3.46B | $3.96B | $4.16B | $4.39B | $4.49B |
| Long-term investments | $138M | $152M | $170M | $155M | $129M |
| Total non-current assets | $9.97B | $10.8B | $11.2B | $11.6B | $11.7B |
| Total assets | $13.2B | $14.1B | $14.5B | $14.7B | $15.2B |
| Accounts payable | $842M | $784M | $811M | $686M | $725M |
| Short-term debt | $126M | $135M | $145M | $169M | $178M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $2.21B | $2.35B | $2.14B | $2.19B | $2.36B |
| Long-term debt | $11.5B | $12B | $12B | $12.2B | $12.6B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $11.8B | $13B | $13.1B | $13.2B | $13.7B |
| Capital lease obligations | $738M | $728M | $777M | $825M | $923M |
| Total liabilities | $14B | $15.4B | $15.3B | $15.4B | $16B |
| Common stock | $1M | $1M | $1M | $1M | $1M |
| Retained earnings | -$-3.57B | -$-4.08B | -$-3.56B | -$-3.43B | -$-3.48B |
| Accumulated other comprehensive income (loss) | -$-9M | -$-10M | -$-14M | -$-21M | -$-14M |
| Total equity | -$-837M | -$-1.32B | -$-824M | -$-734M | -$-810M |
| Total investments | $138M | $152M | $170M | $155M | $129M |
| Total debt | $11.6B | $12.1B | $12.2B | $12.4B | $12.8B |
| Net debt | $11.3B | $12.1B | $12.1B | $12.3B | $12.3B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $676M | -$-516M | -$-133M | $46M | $230M |
| Depreciation and amortization | $426M | $486M | $505M | $534M | $540M |
| Stock-based compensation | $11M | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | $3M | -$-9M | -$-390M | -$-479M | -$-1.38B |
| Accounts receivable | $99M | -$-66M | -$-193M | $22M | -$-136M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | -$-36M | $137M | -$-50M | -$-158M | $16M |
| Net cash provided by operating activities | $543M | $480M | $210M | $300M | -$-131M |
| Investments in property, plant and equipment | -$-335M | -$-360M | -$-467M | -$-415M | -$-469M |
| Acquisitions, net | $1.26B | $152M | $426M | $126M | $5M |
| Net cash used for investing activities | $847M | -$-277M | -$-22M | -$-251M | -$-543M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-2M | -$-1M | -$-4M | -$-8M | -$-5M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | -$-1.17B | -$-204M | -$-268M | -$-438M | -$-495M |
| Net change in cash | $223M | -$-1M | -$-80M | -$-389M | -$-1.17B |
| Cash at end of period | $260M | $37M | $38M | $118M | $507M |
| Operating cash flow | $543M | $480M | $210M | $300M | -$-131M |
| Capital expenditure | -$-335M | -$-360M | -$-467M | -$-415M | -$-469M |
| Free cash flow | $208M | $120M | -$-257M | -$-115M | -$-600M |
Line items
Line items
Line items
About Community Health Systems, Inc.
Community Health Systems, Inc. (CYH) operates as a major healthcare provider across the United States, focusing on the ownership, leasing, and management of general acute care hospitals. The organization offers a comprehensive array of medical services, including emergency care, general and specialized surgical procedures, critical care, internal medicine, obstetrics, and various diagnostic capabilities. Additionally, they provide psychiatric services, rehabilitation programs, skilled nursing, and in-home care. Beyond its hospital-based offerings, the company delivers outpatient services through a diverse network of facilities. These encompass primary care practices, urgent care centers, independent emergency departments, ambulatory surgery centers, advanced imaging and diagnostic centers, retail health clinics, and direct-to-consumer virtual health consultations. As of December 31, 2021, CYH's holdings included 83 hospitals, either owned or leased. This total comprised 81 general acute care facilities and two specialized stand-alone rehabilitation or psychiatric hospitals, collectively providing a capacity of 13,289 licensed patient beds. The company was established in 1985 and its corporate headquarters are situated in Franklin, Tennessee.
- CEO
- Kevin J. Hammons
- Employees
- 57K
- Beta
- 1.81
Included in
Explore
Frequently asked questions
What is the intrinsic value of Community Health Systems, Inc. (CYH)?
InvestorsCraft does not currently publish an intrinsic value for CYH. How the IC value is calculated.
Is CYH undervalued?
InvestorsCraft does not publish an undervaluation signal for CYH at this time.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.